LifeScience Biotech

Ionis and AstraZeneca close deal to develop and commercialize eplontersen

Ionis' investigational antisense medicine for the treatment of transthyretin amyloidosis (ATTR), following expiration of the waiting period under the Hart-...

 January 03, 2022 | News

Clarivate Acquires Patient Connect To Provide Patient-Centric Solutions

 Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced that it...

 December 23, 2021 | News

Novavax Announces Initial Omicron Cross-Reactivity Data from COVID-19 Vaccine Booster

Third dose produced increased immune responses comparable to or exceeding levels associated with protection in Phase 3 clinical trials, with a 9.3-fold IgG...

 December 23, 2021 | News

Merck Expands Neuroinflammatory Pipeline with Acquisition of Chord Therapeutics

Acquisition provides opportunity to develop cladribine in generalized Myasthenia Gravis (gMG) and Neuromyelitis Optica Spectrum Disorder (NMOSD) Cladrib...

 December 22, 2021 | News

BeiGene expands commercial portfolio in China

Strategic collaboration expected to advance clinical development of ociperlimab in combination with tislelizumab, including initiation and funding by Novar...

 December 22, 2021 | News

Microba Life Sciences Becomes First Australian Microbiome Company Granted ISO15189 Accreditation by NATA

he hypothesis-free testing method, MetaPanelTM, can identify multiple pathogens simultaneously from a single sample and was developed in partnership with A...

 December 20, 2021 | News

Sartorius and HOF Sonderanlagenbau Partnership Creates Streamlined Offering of Freeze-Thaw Solutions for Biological Products

Compatible equipment and consumables will allow for quick and streamlined validation of freeze-thaw solutions for customers along with easier purchase an...

 December 16, 2021 | News

Hyris presents new T-Cell test detecting immune responses to SARS-CoV-2

Hyris is going to present its new test to detect the body's T Cell immune response to SARS-CoV-2 on 17 December 2021, at "A-WISH", Alicante-Winter Immunolo...

 December 16, 2021 | News

HKU microbiology researchers collaborating with vaccine manufacturers

After successfully isolating the SARS-CoV-2 Omicron variant from clinical specimens, researchers at the Department of Microbiology at The University of Hon...

 December 14, 2021 | News

Thermo Fisher Scientific Completes Acquisition of PPD, Inc.

We are very excited to officially welcome our PPD colleagues to Thermo Fisher Scientific," said Marc N. Casper, chairman, president and chief executiv...

 December 09, 2021 | News

Servatus to advance autoimmune therapies in Australia

Servatus has raised $7.5 million in an oversubscribed capital raise, with strong support from sophisticated shareholders Funds raised will und...

 December 09, 2021 | News

TransPerfect Life Sciences Acquires LMK Clinical Research Consulting

TransPerfect Life Sciences, a leading provider of services and technologies to support global clinical trials and product development for the biopharmaceut...

 December 07, 2021 | News

Starpharma signs distribution agreement for VIRALEZE™ antiviral nasal spray in Vietnam

Australian biotech company Starpharma has signed a 5-year supply and distribution arrangement for its VIRALEZE™ antiviral nasal spray in&nb...

 December 06, 2021 | News

GenScript, BioComo Join Forces to Accelerate Novel Intranasal SARS-CoV-2 Vaccine Development in Japan

BC-PIV, an innovative non-transmissible viral vector co-developed by BioComo and Mie University, is derived from the recombinant human parainfluenza virus ...

 December 03, 2021 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close